Page last updated: 2024-12-05

6-hydroxyquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-Hydroxyquinoline is a heterocyclic organic compound with the formula C9H7NO. It is a colorless solid that is used in the synthesis of pharmaceuticals and dyes. It is also used as a reagent in organic chemistry. 6-Hydroxyquinoline has been studied for its potential medicinal properties, including its anti-inflammatory, anti-cancer, and antimicrobial effects. The compound is known to act as a chelating agent, binding to metal ions and potentially interfering with their biological function. Its structure lends itself to interaction with biological systems, and it has been shown to exhibit activity against various bacterial and fungal strains. The compound is also a known photosensitizer, and its potential in photodynamic therapy is currently being investigated. 6-Hydroxyquinoline is a versatile compound that has been the subject of extensive research due to its wide range of applications and potential benefits.'

quinolin-6-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11374
CHEMBL ID1908053
CHEBI ID48994
SCHEMBL ID112289
MeSH IDM0193722

Synonyms (52)

Synonym
AC-5108
einecs 209-454-6
brn 0113196
unii-95ru6i7uxl
95ru6i7uxl ,
6-quinolinol (8ci,9ci)
ccris 4331
580-16-5
nsc-26343
nsc26343
6-quinolinol
AC-907/25014237
quinolin-6-ol
6-chinolinol
CHEBI:48994 ,
6-hydroxyquinoline, 95%
6-hydroxyquinoline ,
nsc 26343
1h-1,6-epoxyquinoline
AKOS000277413
ovywmewyejlier-uhfffaoysa-
inchi=1/c9h7no/c11-8-3-4-9-7(6-8)2-1-5-10-9/h1-6,11h
Q0060
A8245
A26208
2,6-dihydroxyquinoline;6-hydroxy-2(1h)-quinolinone
EN300-52757
CHEMBL1908053
BP-13160
FT-0603706
PS-3719
AM20061342
CX1058
quinoline-6-ol
6-hydroxy-quinoline
6-hydroxy-chinolin
SCHEMBL112289
mfcd00047611
SY003116
W-105418
6-quinolinoloxine
DTXSID40206726
CS-W007818
F0001-1515
6-quinolinol, technical, >=95% (hplc)
BBL103626
ccris-4331
hydroxyquinoline, 6-
STL557436
Q27121428
SB67457
Z759294450
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1530048Inhibition of Streptococcus pyogenes SrtA deltaN81 mutant expressed in Escherichia coli BL21(DE3) at 100 uM using Abz-LPETA-Dap(Dnp) as substrate preincubated for 10 mins followed by substrate addition measured every min for 2.5 hrs by fluorimetric assay 2019European journal of medicinal chemistry, Jan-01, Volume: 161Identification of potential antivirulence agents by substitution-oriented screening for inhibitors of Streptococcus pyogenes sortase A.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.86 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]